Free Trial

Microbot Medical (MBOT) Competitors

Microbot Medical logo
$3.18 -0.04 (-1.09%)
As of 01:01 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

MBOT vs. SIBN, BFLY, BVS, AVNS, ZIMV, KIDS, CBLL, SMLR, TMCI, and DCTH

Should you be buying Microbot Medical stock or one of its competitors? The main competitors of Microbot Medical include SiBone (SIBN), Butterfly Network (BFLY), Bioventus (BVS), AVANOS MEDICAL (AVNS), ZimVie (ZIMV), OrthoPediatrics (KIDS), CeriBell (CBLL), Semler Scientific (SMLR), Treace Medical Concepts (TMCI), and Delcath Systems (DCTH). These companies are all part of the "medical equipment" industry.

Microbot Medical vs. Its Competitors

Microbot Medical (NASDAQ:MBOT) and SiBone (NASDAQ:SIBN) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, analyst recommendations, dividends, valuation, earnings and profitability.

In the previous week, Microbot Medical had 5 more articles in the media than SiBone. MarketBeat recorded 15 mentions for Microbot Medical and 10 mentions for SiBone. Microbot Medical's average media sentiment score of 0.45 beat SiBone's score of -0.01 indicating that Microbot Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Microbot Medical
3 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
SiBone
4 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

16.3% of Microbot Medical shares are held by institutional investors. Comparatively, 98.1% of SiBone shares are held by institutional investors. 4.7% of Microbot Medical shares are held by insiders. Comparatively, 4.0% of SiBone shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Microbot Medical has a net margin of 0.00% compared to SiBone's net margin of -12.83%. SiBone's return on equity of -14.20% beat Microbot Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Microbot MedicalN/A -76.27% -67.54%
SiBone -12.83%-14.20%-10.38%

Microbot Medical has a beta of 1.25, suggesting that its stock price is 25% more volatile than the S&P 500. Comparatively, SiBone has a beta of 0.83, suggesting that its stock price is 17% less volatile than the S&P 500.

Microbot Medical presently has a consensus target price of $12.00, suggesting a potential upside of 276.77%. SiBone has a consensus target price of $23.67, suggesting a potential upside of 58.25%. Given Microbot Medical's higher possible upside, analysts clearly believe Microbot Medical is more favorable than SiBone.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Microbot Medical
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
SiBone
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

Microbot Medical has higher earnings, but lower revenue than SiBone. SiBone is trading at a lower price-to-earnings ratio than Microbot Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Microbot MedicalN/AN/A-$11.44M-$0.58-5.49
SiBone$185.26M3.48-$30.91M-$0.56-26.71

Summary

Microbot Medical beats SiBone on 8 of the 15 factors compared between the two stocks.

Get Microbot Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for MBOT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MBOT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MBOT vs. The Competition

MetricMicrobot MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$168.66M$7.02B$6.12B$10.53B
Dividend YieldN/A1.17%5.51%4.67%
P/E Ratio-5.5127.4285.7226.88
Price / SalesN/A197.54581.25184.02
Price / CashN/A22.4126.3031.10
Price / Book18.745.2713.226.67
Net Income-$11.44M$178.04M$3.30B$276.44M
7 Day Performance4.43%3.68%4.78%3.10%
1 Month Performance-12.98%10.34%8.42%10.19%
1 Year Performance246.20%29.85%87.67%40.32%

Microbot Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MBOT
Microbot Medical
2.1001 of 5 stars
$3.19
-1.1%
$12.00
+276.8%
+257.3%$168.66MN/A-5.5120News Coverage
Positive News
Analyst Revision
SIBN
SiBone
3.8918 of 5 stars
$14.49
-0.1%
$23.67
+63.3%
-1.3%$625.54M$167.18M-25.87350News Coverage
BFLY
Butterfly Network
3.1125 of 5 stars
$2.57
+10.1%
$3.00
+17.0%
+30.9%$586.56M$82.06M-9.16460News Coverage
Options Volume
Gap Up
High Trading Volume
BVS
Bioventus
N/A$6.79
-3.3%
N/AN/A$580.41M$573.28M14.041,200
AVNS
AVANOS MEDICAL
2.1329 of 5 stars
$11.57
-1.9%
N/A-50.2%$547.09M$687.80M-1.152,227Positive News
ZIMV
ZimVie
1.4057 of 5 stars
$18.92
-0.1%
$17.75
-6.2%
+18.5%$534.31M$449.75M-27.031,770Positive News
Short Interest ↓
KIDS
OrthoPediatrics
4.6412 of 5 stars
$18.24
-2.8%
$34.14
+87.2%
-29.7%$470.63M$204.73M-10.19200Positive News
CBLL
CeriBell
2.4882 of 5 stars
$12.57
-0.6%
$32.14
+155.7%
N/A$463.43M$65.44M-4.20N/A
SMLR
Semler Scientific
3.3121 of 5 stars
$30.75
+0.6%
$74.25
+141.5%
+23.0%$452.43M$56.29M12.65120
TMCI
Treace Medical Concepts
2.3654 of 5 stars
$6.30
-0.9%
$9.83
+56.1%
+18.0%$401.78M$209.36M-7.97250
DCTH
Delcath Systems
2.7059 of 5 stars
$10.80
-2.7%
$24.50
+126.9%
+23.1%$388.29M$37.21M216.0060Analyst Upgrade

Related Companies and Tools


This page (NASDAQ:MBOT) was last updated on 10/7/2025 by MarketBeat.com Staff
From Our Partners